VIVA Biotech Holdings - ESG Rating & Company Profile powered by AI
Alternative companies in the rating industry group for VIVA Biotech Holdings are shown. This dashboard contains a Q&A table for VIVA Biotech Holdings. This ESG score for VIVA Biotech Holdings represents its transparency towards the UN Sustainable Development Goals.
VIVA Biotech Holdings in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.7; made up of an environmental score of 6.0, social score of 6.4 and governance score of 4.8.
5.7
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
541 | Wntresearch AB | 5.8 | High |
541 | Zenotech Laboratories Ltd | 5.8 | High |
579 | VIVA Biotech Holdings | 5.7 | High |
579 | Caplin Point Laboratories Ltd | 5.7 | High |
579 | Biotest AG | 5.7 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does VIVA Biotech Holdings have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes VIVA Biotech Holdings disclose current and historical energy intensity?
Sign up for free to unlockDoes VIVA Biotech Holdings report the average age of the workforce?
Sign up for free to unlockDoes VIVA Biotech Holdings reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes VIVA Biotech Holdings disclose its ethnicity pay gap?
Sign up for free to unlockDoes VIVA Biotech Holdings disclose cybersecurity risks?
Sign up for free to unlockDoes VIVA Biotech Holdings offer flexible work?
Sign up for free to unlockDoes VIVA Biotech Holdings have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes VIVA Biotech Holdings disclose the number of employees in R&D functions?
Sign up for free to unlockDoes VIVA Biotech Holdings conduct supply chain audits?
Sign up for free to unlockDoes VIVA Biotech Holdings disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes VIVA Biotech Holdings conduct 360 degree staff reviews?
Sign up for free to unlockDoes VIVA Biotech Holdings disclose the individual responsible for D&I?
Sign up for free to unlockDoes VIVA Biotech Holdings disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes VIVA Biotech Holdings disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes VIVA Biotech Holdings disclose water use targets?
Sign up for free to unlockDoes VIVA Biotech Holdings have careers partnerships with academic institutions?
Sign up for free to unlockDid VIVA Biotech Holdings have a product recall in the last two years?
Sign up for free to unlockDoes VIVA Biotech Holdings disclose incidents of discrimination?
Sign up for free to unlockDoes VIVA Biotech Holdings allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas VIVA Biotech Holdings issued a profit warning in the past 24 months?
Sign up for free to unlockDoes VIVA Biotech Holdings disclose parental leave metrics?
Sign up for free to unlockDoes VIVA Biotech Holdings disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes VIVA Biotech Holdings disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes VIVA Biotech Holdings disclose the pay ratio of women to men?
Sign up for free to unlockDoes VIVA Biotech Holdings support suppliers with sustainability related research and development?
Sign up for free to unlockDoes VIVA Biotech Holdings disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes VIVA Biotech Holdings reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs VIVA Biotech Holdings involved in embryonic stem cell research?
Sign up for free to unlockDoes VIVA Biotech Holdings disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes VIVA Biotech Holdings disclose its waste policy?
Sign up for free to unlockDoes VIVA Biotech Holdings report according to TCFD requirements?
Sign up for free to unlockDoes VIVA Biotech Holdings disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes VIVA Biotech Holdings disclose energy use targets?
Sign up for free to unlockDoes VIVA Biotech Holdings disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes VIVA Biotech Holdings have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for VIVA Biotech Holdings
These potential risks are based on the size, segment and geographies of the company.
Viva Biotech Holdings, an investment holding company, provides structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide. The company provides discovery biology services, include protein expression and purification, structural biology, hit discovery, bioassay, biomolecular interaction, and pharmacokinetics; chemistry services, such as medicinal and synthetic chemistry, analytical chemistry, purification preparation, and computer-aided drug design services, as well as offers chemical technology platforms; and antibody drug research and development services, include antigen preparation, multi-species discovery, monoclonal antibodies, antibodies functional screening and identification, antibody engineering transformation, antibody characteristics, and antibody cell line engineering transformation, as well as offers technology platforms, such as hybridoma, phage and yeast display, mammalian display, VHH antibody technology, high throughput sequencing, computer-aided drug design, HDX-MS, crystal structure determination of protein, and SPR technology. It also provides cell lines, crystal structures, GPCR proteins, antibodies, and proteins. In addition, the company offers contract development and manufacturing services for small molecule active pharmaceutical ingredients (APIs) and intermediates; and trades in APIs, intermediates, and formulations, as well as equity for service. Further, it provides research service; laboratory rental services; and project management and bidding services, as well as sells compounds. The company was incorporated in 2008 and is headquartered in Shanghai, China.